ASSOCIATION ENTRE AGONISTES DE LA DOPAMINE ET SÉCRÉTAGOGUES D'INSULINE DE PHASE 1, DESTINÉE AU TRAITEMENT DE TROUBLES DU MÉTABOLISME

• 收藏
• 分享

专利权人:

VEROSCIENCE LLC

发明人:

CINCOTTA, ANTHONY, H.

申请号：

EP10784223

公开号：

EP2437732A4

申请日:

2010.06.07

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The invention provides one or more agents that increase central dopaminergic neuronal activity selected from bromocriptine, lisuride, hydergine, dihydroergocriptine and/or dihydroergotoxine, plus a first-phase insulin secretagouge (FPIS), for use in treating prediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance or Type 2 Diabetes, wherein the FPIS is glucagon like peptide-1 (GLP-1), insulin or a GLP-1 receptor agonist, wherein said agent is administered to a human to increase central dopaminergic activity primarily within 4 hours of waking in the morning.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/